Diabetes Mellitus: New Technologies at the Heart of Modern Therapy
Diabetes mellitus is one of the top three diseases worldwide that most often lead to disability and death. In Russia, the number of patients with diabetes has increased 2.5-fold over the past 20 years. The rapid development of new age medicine has opened up new opportunities in the diagnosis and treatment of this complex disease. The development of molecular genetic research has made it possible to improve diagnosis and use a personalized approach to treatment. The use of modern antidiabetic drugs helps prevent the development of acute complications and delay the development of cardiovascular complications in type II diabetes. The development of drugs for immunotherapy of type I diabetes is underway. The emergence of new medical devices and digital technologies, including continuous glucose monitors, smart insulin pens, feedback-enabled insulin pumps, personal health assistants, mobile apps, telemedicine services, and AI systems have significant potential to improve the quality of care and treatment outcomes. Technologies such as bionic or artificial pancreas are expected in the future, with high hopes for the application of stem cell technologies. What innovative technologies for the treatment of diabetes are now available globally and are accessible in Russia? What promising developments in medicines and medical devices are taking place in our country? What technologies are most needed medically? How can we accelerate the introduction of digital technologies into the treatment of patients with diabetes? Which best practices from foreign countries can be used in our country?
Anastasia Stolkova, First Deputy Chief Executive Officer for Development, Director of the Healthcare Directorate, Roscongress Foundation
Elena Aksenova, Director, Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department
Gagik Galstyan, President, Russian Diabetes Association (online)
Vasily Generalov, President, Regional Public Organization for Assistance to Patients with Epilepsy "Project" Don't Be Afraid"
Roman Dray, Director of the Research Centre, GEROPHARM
Svetlana Kanevskaya, Medical Director, Medscan Group
Sergei Lukyanov, Rector, Pirogov Russian National Research Medical University
Natalia Mokrysheva, Director, National Medical Research Center for Endocrinology Ministry of Health of the Russian Federation (online)
Elena Petryaykina, Director, Russian Children's Clinical Hospital of the Russian National Research Medical University named after N.I. Pirogov
Front row participants
Bulat Valitov, Doctor of the Russian Mini-Football Team for People with Diabetes; Head, Author's Online Diabetes School
Tamara Kozyreva, Head, Help First Project